Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure 5 from Safety and Efficacy of Intratumoral MEDI1191, an IL12 mRNA Lipid Nanoparticle, plus Intravenous Durvalumab in Patients with Advanced Solid Tumors: A First-in-Human Study
  1. Home
  2. Publications
  3. Supplementary Figure 5 from Safety and Efficacy of Intratumoral MEDI1191, an IL12 mRNA Lipid Nanoparticle, plus Intravenous Durvalumab in Patients with Advanced Solid Tumors: A First-in-Human Study

Supplementary Figure 5 from Safety and Efficacy of Intratumoral MEDI1191, an IL12 mRNA Lipid Nanoparticle, plus Intravenous Durvalumab in Patients with Advanced Solid Tumors: A First-in-Human Study

Authors:
  • Benedito A. Carneiro
    Benedito A. Carneiro
  • TMThomas Marron
    Thomas Marron
  • DZDmitriy Zamarin
    Dmitriy Zamarin
  • ECEduardo Castañón
    Eduardo Castañón
  • SPSandip Pravin Patel
    Sandip Pravin Patel
  • VSVivek Subbiah
    Vivek Subbiah
  • IMInderjit Mehmi
    Inderjit Mehmi
  • AEAnthony El-Khoueiry
    Anthony El-Khoueiry
  • AOArjun Oberoi
    Arjun Oberoi
  • MAMichael Abadier
    Michael Abadier
  • EJEmily C. Jennings
    Emily C. Jennings
  • VDVincent Dubois
    Vincent Dubois

Open Access
Publisher website
Google Scholar
  • 2 November 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.34885139
Abstract
No abstract available
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE I CLINICAL TRIALS
  • IMMUNOTHERAPY
  • CHECKPOINT BLOCKADE
  • COMBINATION IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.